Mike Kalogiannis is a Senior Associate in the Publications Management Team within External Medical Communications at Pfizer.
Prior to joining Pfizer, Mike taught medical and biological science courses at local colleges and universities. He also conducted research on sleep and neurodegeneration, and authored publications in European Journal of Neuroscience, PLoS One, Frontiers in Neuroscience, and BBA: Molecular Basis of Disease. He also coauthored a chapter in Narcolepsy: Pathophysiology, Diagnosis and Treatment and presented posters at The Society for Neuroscience and American Society for Neurochemistry.
Mike is a graduate of Cornell University. He earned a PhD from New York Medical College, and an MBA from Stony Brook University.